Peter Johann
Chairman & CEO Lumendi (Rhein-Neckar)
Peter Johann is the Founder and CEO of Lumendi, a pioneer endosurgery tech company. Their primary focus is to create technologies that enable physicians to perform at a much higher level than usual while also minimizing risk and recovery time for patients. Striving to discover new ways to perform even complex surgeries more safely while being efficient and less invasively.
Peter Johann is also a Managing General Partner of NGN Capital, a venture capital firm dedicated to healthcare and biotechnology investments of all sorts, focusing mainly on ventures with the potential to achieve above-average private equity returns. Peter joined NGN Capital from Boehringer Ingelheim, where he was the Division Head of Corporate Development.
He established an international network in the biotech and pharmaceutical industries. At Boehringer Ingelheim, his responsibilities were to design plans and projects, M&A, business development, and licensing.
He is also a Board Member and a Member of the Compensation Committee of Vivaldi Biosciences which is a biotech company that is developing NS1 vaccines for protection against epidemic and pandemic viral respiratory diseases.
Peter Johann is an investment expert, but he is also a kind soul with a deep passion for healthcare and biotechnology to help people worldwide.
Peter’s roles include:
- Founder and CEO at Lumendi: https://lumendi.com/
- LinkedIn: https://www.linkedin.com/company/lumendi/
- Managing General Partner at NGN Capital: https://www.ngncapital.com/
- Board Member and Member at the Compensation Committee of Vivaldi Biosciences: https://vivaldibiosciences.com/
- LinkedIn: https://www.linkedin.com/company/vivaldi-biosciences-inc-/
Peter Johann is a Global Investment Leaders Club member: “I have been a member of the Club for around 2 amazing years. I enjoy the conversations, to get input from different areas, looking at trends, not only in the healthcare industry where I am from but also to learn what’s going on around the world, which could also impact my life. There are always different experiences around the table, different aspects of investing and how to move things forward and progress. And last week I’ve had an opportunity on a deeper discussion with all the members about the development of my company. I enjoy being here and enjoy the environment very much.”